Prevalence of complications and co‐morbidities in males and females with obesity: Real‐world insights from claims data analysis

Documenti analoghi

• Prevalence of obesity and cardiovascular disease in adults with type 2 diabetes and use of diabetes medication in Germany: A claims data study
  di: Nora Hennies, et al.
  Pubblicazione: (2024)
• Eloralintide, a selective, long‐acting amylin receptor agonist for treatment of obesity: Phase 1 proof of concept
  di: Shobha Bhattachar, et al.
  Pubblicazione: (2026)
• Real‐world insights into incretin‐based therapy: Associations between changes in taste perception and appetite regulation in individuals with obesity and overweight: A cross‐sectional study
  di: Ali Kapan, et al.
  Pubblicazione: (2025)
• Real‐world titration, persistence & weight loss of semaglutide and tirzepatide in an academic obesity clinic
  di: Jason M. Samuels, et al.
  Pubblicazione: (2025)
• Impact of early and tight HbA1c control on the risk of long‐term complications and cardiovascular death in patients with type 2 diabetes from the Swedish National Diabetes Register
  di: Julie Mount, et al.
  Pubblicazione: (2026)